Recall of VIDAS FSH

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by BioMerieux SA.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    79620
  • Event Risk Class
    Class 2
  • Event Number
    Z-2331-2018
  • Event Initiated Date
    2018-04-09
  • Event Date Posted
    2018-06-29
  • Event Status
    Open, Classified
  • Event Country
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Radioimmunoassay, follicle-stimulating hormone - Product Code CGJ
  • Reason
    Invalid calibration with low calibrator s1 while using the product.
  • Action
    The recalling firm issued letters to the end users dated April 2018, via FedEx 2 Day Express explaining the issue, potential risk to health, and requested the impacted lots be destroyed. For further questions, please call (314) 731-8805.

Device

  • Model / Serial
    Lot #1005888210 was distributed in the U.S.
  • Product Classification
  • Device Class
    1
  • Implanted device?
    No
  • Distribution
    Distribution was made to the recalling firm's distribution center in KY. There was no military/government distribution.
  • Product Description
    VIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, 376, Chemin de l'Orme, 69280 March-l'Etoile - France. || Intended for use on the instruments of the VIDAS family (VITEK ImmunoDiagnostic Assay System) as an automated quantitative enzyme-linked fluorescent immunoassay (ELFA) for the determination of human follicle stimulating hormone (FSH) concentration in human serum or plasma (heparin). It is intended for use as an aid in the diagnosis of pituitary gland and gonadal disorders.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    BioMerieux SA, Chemin De L'Orme, Marcy L'Etoile France
  • Manufacturer Parent Company (2017)
  • Source
    USFDA